COYANasdaq United States
Market cap
$112.829 M
$4.81 +5.02%
Close of 7 Aug 2026
Revenue
$7.95M
#3214 by revenue
Earnings
-$21.2M
Loss-making
Shares outstanding
23,457,183
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Coya Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.